EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Improved gonadal hormones levels following 6 and 12 months of anti-retroviral therapy among men living with human immunodeficiency virus infection

Shabani Iddi iD, Haruna Dika, Karol J Marwa, Benson R Kidenya, Samuel E Kalluvya

PLOS One · 2025

DOI: 10.1371/journal.pone.0324374 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Shabani Iddi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania. Hauptthemen laut MEDLINE: HIV Infections, Hypogonadism, Anti-Retroviral Agents, Gonadal Hormones. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Male hypogonadism is commonly reported in men living with human immunodeficiency virus (HIV) (MLWH), reaching a prevalence of up to 89% and shown to decrease in the antiretroviral therapy (ART) era as compared to pre-ART era. Data regarding the effect of ART on gonadal hormones levels are scarce. We aimed to determine changes in gonadal hormones levels in HIV males following ART initiation.

Methods

This was a longitudinal study involving newly diagnosed ART naïve MLWH in Mwanza, Tanzania. All enrolled participants underwent thorough clinical and physical examination including anthropometric measurements. A pre-structured questionnaire was used to collect socio-demographic and clinical data. Serum total testosterone (TT), follicle-stimulating hormone (FSH), luteinizing hormone (LH) and estradiol were estimated at baseline, six and twelve months after ART initiation. Serum TT < 300 ng/dl, or ≥300 ng/dl with high LH and FSH were taken as markers of hypogonadism. Data were analyzed using STATA version 15.

Results

A total of 213 participants were enrolled in this study. Between individual’s pairs, the median levels of TT and LH after six and twelve months were found to be significantly higher while estradiol was significantly lower than at baseline (p < 0.001). Between after six and after twelve months, only median estradiol levels showed significant change with levels being lower after twelve months (p < 0.001). The change in FSH was not statistically significant. Of the 89 participants (41.8%) who had hypogonadism at baseline, 44 (49.4%) normalized TT (≥300 ng/ml) and had higher median testosterone than those who did not normalize. Furthermore, there was a statistically significant association between testosterone change and initial viral load (p = 0.049), WHO clinical stage (p = 0.031) and baseline hypogonadism status (p = 0.014).

Conclusion

This study concludes that TT improved significantly after ART initiation. Particularly, half of the MLWH who presented with low TT at baseline normalized it within the first year of treatment. Therefore, ART reduces prevalence of hypogonadism and baseline TT seems to be predictive of future evolution of the hypogonadism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHypogonadismAnti-Retroviral AgentsGonadal HormonesHumansMaleAdultTestosteroneLongitudinal StudiesLuteinizing HormoneFollicle Stimulating HormoneMiddle AgedEstradiolTanzania

Substanzen

TestosteroneLuteinizing HormoneFollicle Stimulating HormoneEstradiolAnti-Retroviral AgentsGonadal Hormones

Autor:innen und Institutionen

  • Department of Physiology, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
  • Department of Pharmacology, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
  • Department of Biochemistry and molecular biology, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
  • Department of Internal Medicine, Weill Bugando School of Medicine, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.

ORCID-Profile: Shabani Iddi

Zitieren

APA

Iddi, S., Dika, H., Marwa, K. J., Kidenya, B. R., & Kalluvya, S. E. (2025). Improved gonadal hormones levels following 6 and 12 months of anti-retroviral therapy among men living with human immunodeficiency virus infection. PLOS One. https://doi.org/10.1371/journal.pone.0324374

Vancouver

Iddi S, Dika H, Marwa KJ, Kidenya BR, Kalluvya SE. Improved gonadal hormones levels following 6 and 12 months of anti-retroviral therapy among men living with human immunodeficiency virus infection. PLOS One. 2025. doi:10.1371/journal.pone.0324374

BibTeX
@article{Iddi2025,
  author = {Iddi, Shabani and Dika, Haruna and Marwa, Karol J and Kidenya, Benson R and Kalluvya, Samuel E},
  title = {Improved gonadal hormones levels following 6 and 12 months of anti-retroviral therapy among men living with human immunodeficiency virus infection},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0324374}
}
Kostenlos starten →